Security record · archived quarter
NVCR
Novocure Ltd · Healthcare · Medical - Devices
13Tracked holders
0Δ holders
14.54MShares held
$227.34MReported value
+0New positions
−0Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -0.2% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 119.64K | $1.43M | n/a | n/a |
| Q2 2026 | 91 | +1 | 75.35M | $1.14B | +7 | −6 |
| Q1 2026 | 93 | -1 | 69.74M | $759.20M | +6 | −7 |
| Q4 2025 | 93 | -2 | 74.88M | $967.62M | n/a | −2 |
| Q3 2025 | 19 | 0 | 56.46M | $729.50M | n/a | n/a |
| Q2 2025 | 16 | +1 | 59.30M | $1.06B | +2 | −1 |
| Q1 2025 | 12 | -3 | 16.40M | $292.30M | n/a | −3 |
| Q4 2024 | 15 | +1 | 16.08M | $479.25M | +1 | n/a |
| Q3 2024 | 13 | 0 | 14.54M | $227.34M | n/a | n/a |
| Q2 2024 | 13 | n/a | 14.57M | $249.63M | n/a | n/a |
Who holds it · Q3 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 4.31M | +86.7% | $67.34M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 2.41M | +1.3% | $37.60M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | T. Rowe Price ✦ | 2.32M | +7.7% | $36.30M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | Baillie Gifford ✦ | 1.66M | -1.7% | $25.94M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 5 | Marshall Wace ✦ | 779.67K | +56.7% | $12.19M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 744.15K | -2.1% | $11.63M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 739.95K | -40.5% | $11.57M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 650.31K | -7.0% | $10.16M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Coatue Management ✦ | 608.67K | 0.0% | $9.51M | 0.0% | Held | 2 | SEC ↗ |
| 10 | Millennium Management ✦ | 270.81K | -77.5% | $4.23M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Bridgewater Associates ✦ | 39.38K | -51.5% | $615,556 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 16.51K | -96.2% | $257,123 | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 13 | Citadel Advisors ✦ | 52 | -100.0% | $813 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 221 holders, 97.96M shares, $1.02B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2024 ·
Methodology ·
Get this via the API